Cargando…
Study on Biopharmaceutics Classification and Oral Bioavailability of a Novel Multikinase Inhibitor NCE for Cancer Therapy
Specific biopharmaceutics classification investigation and study on phamacokinetic profile of a novel drug candidate (2-methylcarbamoyl-4-{4-[3- (trifluoromethyl) benzamido] phenoxy} pyridinium 4-methylbenzenesulfonate monohydrate, NCE) were carried out. Equilibrium solubility and intrinsic dissolut...
Autores principales: | Yang, Yang, Fan, Chun-Mei, He, Xuan, Ren, Ke, Zhang, Jin-Kun, He, Ying-Ju, Yu, Luo-Ting, Zhao, Ying-Lan, Gong, Chang-Yang, Zheng, Yu, Song, Xiang-Rong, Zeng, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057667/ https://www.ncbi.nlm.nih.gov/pubmed/24776763 http://dx.doi.org/10.3390/ijms15057199 |
Ejemplares similares
-
Drying Technologies for the Stability and Bioavailability of Biopharmaceuticals
por: Emami, Fakhrossadat, et al.
Publicado: (2018) -
Investigation of the Factors Responsible for the Poor Oral Bioavailability of Acacetin in Rats: Physicochemical and Biopharmaceutical Aspects
por: Han, Dong-Gyun, et al.
Publicado: (2021) -
Structural insights into the substrate tunnel of Saccharomyces cerevisiae carbonic anhydrase Nce103
por: Teng, Yan-Bin, et al.
Publicado: (2009) -
Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib
por: Lin, Tong, et al.
Publicado: (2017) -
Use of a Bayesian approach in the design and evaluation of NCE2s
por: Wang, Chao-Yi, et al.
Publicado: (2017)